Pharmacologic Pain Management for Older Adults with CKD
For patients over 65 with chronic pain and CrCl <60 mL/min, start with acetaminophen as first-line therapy, add topical NSAIDs or duloxetine for inadequate relief, and avoid oral NSAIDs, meperidine, and propoxyphene entirely. 1, 2
First-Line Therapy
Acetaminophen is the preferred initial agent for chronic pain in this population 2. It requires no renal dose adjustment and has the safest profile in kidney impairment. Start with 325-500 mg every 6-8 hours, maximum 3g daily in older adults.
Second-Line Options
When acetaminophen fails to achieve pain control goals:
For Neuropathic Pain
Duloxetine (SNRI): Preferred over tricyclics due to superior safety profile 1, 3
- Start 20-30 mg daily, titrate slowly
- More favorable than TCAs in older adults
Gabapentinoids: Require significant dose reduction in CrCl <60
- Gabapentin: Start 100 mg daily, extend dosing intervals
- Pregabalin: Start 25-50 mg daily
- Both accumulate with renal impairment 3
Secondary amine TCAs (nortriptyline, desipramine): Only if SNRIs fail 1, 4
- Lower anticholinergic burden than tertiary amines
- Avoid amitriptyline and doxepin 4
For Musculoskeletal Pain
Topical NSAIDs: Preferred over oral formulations 1, 2
- Minimal systemic absorption
- Use for focal/regional pain
Topical lidocaine: Safe alternative for localized pain 1
Medications to Avoid
Absolutely contraindicated in this population 5, 4:
- Meperidine (renally cleared toxic metabolite causes seizures)
- Propoxyphene (renally cleared active metabolite accumulation)
- Oral NSAIDs long-term (GI bleeding, acute kidney injury, cardiovascular risk) 2
- Ketorolac, indomethacin, piroxicam 4
Opioid Considerations
Reserve opioids for severe, refractory pain only 6, 2:
Tramadol: Start 25 mg daily, extend intervals to every 12 hours with CrCl <30
- Carries seizure and serotonin syndrome risk
- Cognitive side effects common 3
If stronger opioids needed: Prefer agents without active renally-cleared metabolites
- Avoid codeine (morphine metabolite accumulates)
- Fentanyl transdermal may be safer option 6
Critical Prescribing Principles
- "Start low, go slow": Begin all centrally-acting drugs at lowest dose with gradual titration 1
- Extend dosing intervals: Most renally-cleared drugs require longer intervals, not just lower doses 5
- Monitor closely: Assess for cognitive effects, falls, constipation at each dose change 6
- Discontinue ineffective drugs: Don't continue medications that aren't meeting pain goals 1
Common Pitfalls
The evidence shows propoxyphene and meperidine reached consensus as inappropriate specifically because their renally-cleared metabolites accumulate and cause serious adverse events 5. Despite this, they may still appear in older formularies—never prescribe these in renal impairment.
Gabapentinoids have mixed evidence for efficacy 3 but definite evidence for accumulation in renal disease. Many prescribers under-adjust doses, leading to sedation and falls.